263 related articles for article (PubMed ID: 21752725)
1. Prognostic significance of miR-215 in colon cancer.
Karaayvaz M; Pal T; Song B; Zhang C; Georgakopoulos P; Mehmood S; Burke S; Shroyer K; Ju J
Clin Colorectal Cancer; 2011 Dec; 10(4):340-7. PubMed ID: 21752725
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells.
Song B; Wang Y; Titmus MA; Botchkina G; Formentini A; Kornmann M; Ju J
Mol Cancer; 2010 Apr; 9():96. PubMed ID: 20433742
[TBL] [Abstract][Full Text] [Related]
3. MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL.
Baraniskin A; Birkenkamp-Demtroder K; Maghnouj A; Zöllner H; Munding J; Klein-Scory S; Reinacher-Schick A; Schwarte-Waldhoff I; Schmiegel W; Hahn SA
Carcinogenesis; 2012 Apr; 33(4):732-9. PubMed ID: 22287560
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of microRNA-93 downregulation in human colon cancer.
Xiao ZG; Deng ZS; Zhang YD; Zhang Y; Huang ZC
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):296-301. PubMed ID: 23354160
[TBL] [Abstract][Full Text] [Related]
5. Sequential expression of miR-182 and miR-503 cooperatively targets FBXW7, contributing to the malignant transformation of colon adenoma to adenocarcinoma.
Li L; Sarver AL; Khatri R; Hajeri PB; Kamenev I; French AJ; Thibodeau SN; Steer CJ; Subramanian S
J Pathol; 2014 Dec; 234(4):488-501. PubMed ID: 25269767
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.
Schetter AJ; Leung SY; Sohn JJ; Zanetti KA; Bowman ED; Yanaihara N; Yuen ST; Chan TL; Kwong DL; Au GK; Liu CG; Calin GA; Croce CM; Harris CC
JAMA; 2008 Jan; 299(4):425-36. PubMed ID: 18230780
[TBL] [Abstract][Full Text] [Related]
7. Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability.
Donada M; Bonin S; Nardon E; De Pellegrin A; Decorti G; Stanta G
J Cancer Res Clin Oncol; 2011 Feb; 137(2):201-10. PubMed ID: 20387074
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
Wang X; Wang J; Ma H; Zhang J; Zhou X
Med Oncol; 2012 Jun; 29(2):919-27. PubMed ID: 21390519
[TBL] [Abstract][Full Text] [Related]
9. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.
Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK
Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle proteins predict recurrence in stage II and III colon cancer.
Belt EJ; Brosens RP; Delis-van Diemen PM; Bril H; Tijssen M; van Essen DF; Heymans MW; Beliën JA; Stockmann HB; Meijer S; Meijer GA
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S682-92. PubMed ID: 22311118
[TBL] [Abstract][Full Text] [Related]
11. Thymidylate synthase expression and outcome of patients receiving pemetrexed for advanced nonsquamous non-small-cell lung cancer in a prospective blinded assessment phase II clinical trial.
Nicolson MC; Fennell DA; Ferry D; O'Byrne K; Shah R; Potter V; Skailes G; Upadhyay S; Taylor P; André V; Nguyen TS; Myrand SP; Visseren-Grul C; Das M; Kerr KM
J Thorac Oncol; 2013 Jul; 8(7):930-9. PubMed ID: 23722170
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence.
Alaiyan B; Ilyayev N; Stojadinovic A; Izadjoo M; Roistacher M; Pavlov V; Tzivin V; Halle D; Pan H; Trink B; Gure AO; Nissan A
BMC Cancer; 2013 Apr; 13():196. PubMed ID: 23594791
[TBL] [Abstract][Full Text] [Related]
13. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
[TBL] [Abstract][Full Text] [Related]
14. Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma.
Schetter AJ; Nguyen GH; Bowman ED; Mathé EA; Yuen ST; Hawkes JE; Croce CM; Leung SY; Harris CC
Clin Cancer Res; 2009 Sep; 15(18):5878-87. PubMed ID: 19737943
[TBL] [Abstract][Full Text] [Related]
15. Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancer.
Weissmann-Brenner A; Kushnir M; Lithwick Yanai G; Aharonov R; Gibori H; Purim O; Kundel Y; Morgenstern S; Halperin M; Niv Y; Brenner B
Int J Oncol; 2012 Jun; 40(6):2097-103. PubMed ID: 22426940
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
[TBL] [Abstract][Full Text] [Related]
17. Prognostic values of the miR-17-92 cluster and its paralogs in colon cancer.
Yu G; Tang JQ; Tian ML; Li H; Wang X; Wu T; Zhu J; Huang SJ; Wan YL
J Surg Oncol; 2012 Sep; 106(3):232-7. PubMed ID: 22065543
[TBL] [Abstract][Full Text] [Related]
18. Identification of a functional polymorphism within the 3'-untranslated region of denticleless E3 ubiquitin protein ligase homolog associated with survival in acral melanoma.
Yang L; Dai J; Ma M; Mao L; Si L; Cui C; Sheng X; Chi Z; Yu S; Xu T; Yu J; Kong Y; Guo J
Eur J Cancer; 2019 Sep; 118():70-81. PubMed ID: 31325875
[TBL] [Abstract][Full Text] [Related]
19. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
[TBL] [Abstract][Full Text] [Related]
20. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
